These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23552044)

  • 1. Testing the predictive ability of the "spinal cord injury equation" in estimating vancomycin clearance.
    Lee JP; Wang YJ
    Am J Health Syst Pharm; 2013 Apr; 70(8):669-74. PubMed ID: 23552044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of methods to estimate glomerular filtration rate versus actual drug clearance in patients with chronic spinal cord injury.
    Lee JP; Dang AT
    Spinal Cord; 2011 Dec; 49(12):1158-63. PubMed ID: 21788951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury--does the use of cystatin C improve accuracy?
    DeCarolis DD; Thorson JG; Marraffa RA; Clairmont MA; Kuskowski MA
    Ther Drug Monit; 2014 Oct; 36(5):632-9. PubMed ID: 25222855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Analysis of Various Dosing Methods for Aminoglycosides and Vancomycin Therapy in Chronic Spinal Cord Injury Patients.
    Lee JP; Truong TT
    Nephron; 2015; 131(1):66-72. PubMed ID: 26330088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-dose gentamicin clearance is a predictor of creatinine clearance in spinal man.
    Segal JL; Gilman TA; Thompson JF
    Am J Ther; 2010; 17(4):390-5. PubMed ID: 19531933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin pharmacokinetics in spinal cord injured patients: a comparison with age-matched, able-bodied controls.
    Lavezo LA; Davis RL
    J Spinal Cord Med; 1995 Oct; 18(4):233-5. PubMed ID: 8591068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A More Accurate Method to Estimate Aminoglycoside Clearance From Serum Creatinine in Patients With Spinal Cord Injury.
    Lee JP; Truong TT
    J Pharm Technol; 2015 Jun; 31(3):115-119. PubMed ID: 34860964
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive performance of a vancomycin-aminoglycoside population model.
    Beringer PM; Wong-Beringer A; Rho JP
    Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of gentamicin. Estimation of initial dosing parameters in hospitalized patients at Al-Amiri Hospital Kuwait.
    Al-Lanqawi Y; Capps P; Abudlmalek K; Al-Anezi K; Thusu A; Sharma P
    Med Princ Pract; 2009; 18(3):209-16. PubMed ID: 19349724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
    Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
    J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bayesian forecasting of plasma vancomycin concentration using time-dependent pharmacokinetics].
    Nakamura T; Wakaki N; Kimura Y; Goto N; Masada M
    Yakugaku Zasshi; 1996 Nov; 116(11):876-83. PubMed ID: 8981831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of glomerular filtration rate on the clearance of vancomycin administered by continuous infusion in burn patients.
    Dailly E; Le Floch R; Deslandes G; Pannier M; Jolliet P
    Int J Antimicrob Agents; 2008 Jun; 31(6):537-9. PubMed ID: 18462925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
    Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
    J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
    Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
    J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin monitoring: one or two serum levels?
    Andrés I; López R; Pou L; Piñol F; Pascual C
    Ther Drug Monit; 1997 Dec; 19(6):614-9. PubMed ID: 9421100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing two predictive methods for determining serum vancomycin concentrations at a Veterans Affairs Medical Center.
    Lee E; Winter ME; Boro MS
    Am J Health Syst Pharm; 2006 Oct; 63(19):1872-5. PubMed ID: 16990634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of riluzole in acute spinal cord injury.
    Chow DS; Teng Y; Toups EG; Aarabi B; Harrop JS; Shaffrey CI; Johnson MM; Boakye M; Frankowski RF; Fehlings MG; Grossman RG
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):129-40. PubMed ID: 22985379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parameters.
    Murphy JE; Gillespie DE; Bateman CV
    Am J Health Syst Pharm; 2006 Dec; 63(23):2365-70. PubMed ID: 17106010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of vancomycin in adult and geriatric patients: comparison of eleven approaches.
    Sánchez JL; Dominguez AR; Lane JR; Anderson PO; Capparelli EV; Cornejo-Bravo JM
    Int J Clin Pharmacol Ther; 2010 Aug; 48(8):525-33. PubMed ID: 20650044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.